Skip to main content

RHUMBLINE ADVISERS

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 1115418 BOSTON, MA

Position in KALV

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$955,550
+$190,186 QoQ
Shares Held
47,469
+0.2% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 23.16248499020413.ToString("F0")% Shared 0.ToString("F0")% None 76.83751500979587.ToString("F0")%

Common Shares in KALV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. KALV ranks #120 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KALV

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $955,550 47,469
2025-12-31 $765,364 47,391
2025-09-30 $643,079 52,798
2025-06-30 $614,720 54,376
2025-03-31 $610,673 52,918
2024-12-31 $433,291 51,156
2024-09-30 $582,230 50,279
2024-06-30 $627,025 53,228
2024-03-31 $561,215 47,320
2023-12-31 $555,672 45,361
2023-09-30 $403,448 41,895
2023-06-30 $375,579 41,731
2023-03-31 $305,140 38,822
2022-12-31 $254,074 37,585
2022-09-30 $544,313 37,513
2022-06-30 $341,142 34,669
2022-03-31 $326,491 22,150
2021-12-31 $252,031 19,050
2021-09-30 $332,614 19,061
2021-06-30 $435,209 18,164
2021-03-31 $595,417 23,177
2020-12-31 $360,601 18,989
2020-09-30 $198,330 15,753
2020-06-30 $213,565 17,650
2020-03-31 $82,061 10,727